Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy.
Tsutomu TakeuchiRoy M FleischmannNoriko IikuniHarry ShiKoshika SomaJerome PaulissenTomohiro HiroseJosef S SmolenPublished in: Arthritis research & therapy (2021)
ClinicalTrials.gov, NCT02187055. Registered on 08 July 2014.